Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1365
Embargo will expire:
23-Oct-2018 11:00 AM EDT
Released to reporters:
18-Oct-2018 11:30 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-Oct-2018 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Cardinezetal.jpg
  • Embargo expired:
    18-Oct-2018 9:00 AM EDT

Article ID: 702172

Researchers Describe Novel Immune Syndrome

The Rockefeller University Press

Researchers from Australia and Japan have discovered a new human immunodeficiency syndrome in two patients on separate continents. The study, which will be published October 18 in the Journal of Experimental Medicine, reveals that a mutation in a gene called IKBKB disrupts the immune system, leading to excessive inflammation and the loss of both T and B white blood cells.

Released:
15-Oct-2018 9:45 AM EDT

Article ID: 702338

Researcher Wins Breakthrough Prize for Innate Immunity Discovery

UT Southwestern Medical Center

UT Southwestern biochemist Dr. Zhijian “James” Chen today was named winner of the prestigious 2019 Breakthrough Prize in Life Sciences for his discovery of the cGAS enzyme that launches the body’s immune defense against infections and cancers. That enzyme patrols the cell’s interior and triggers the immune system in response to DNA.

Released:
17-Oct-2018 10:05 AM EDT
Embargo will expire:
20-Oct-2018 5:30 PM EDT
Released to reporters:
16-Oct-2018 2:30 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 20-Oct-2018 5:30 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

  • Embargo expired:
    15-Oct-2018 3:00 PM EDT

Article ID: 701981

Polio: Environmental Monitoring Will Be Key as World Reaches Global Eradication

University of Michigan

Robust environmental monitoring should be used as the world approaches global eradication of polio, say University of Michigan researchers who recently studied the epidemiology of the 2013 silent polio outbreak in Rahat, Israel.

Released:
10-Oct-2018 12:00 PM EDT

Article ID: 701899

AAPS Announces Six Fellowships, One of the Highest Organizational Honors

American Association of Pharmaceutical Scientists (AAPS)

The American Association of Pharmaceutical Scientists (AAPS) is pleased to announce the elevation of six recipients to AAPS Fellow (FAAPS), one of the highest honors given to members of the association. Each year

Released:
15-Oct-2018 12:05 PM EDT
GabrilovichDmitry.jpg
  • Embargo expired:
    15-Oct-2018 11:00 AM EDT

Article ID: 702165

Function of Neutrophils During Tumor Progression Unraveled

Wistar Institute

Wistar researchers have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and facilitate tumor cell seeding and establishment of metastasis.

Released:
15-Oct-2018 8:05 AM EDT
VogeleLife.jpg

Article ID: 702143

The Easy Way May Not Be the Best

New York University

The steps cells take in response to challenges are more complex than previously thought, finds new research. The study investigates a system relevant to cancer, viral infection, and diabetes.

Released:
15-Oct-2018 8:00 AM EDT

Article ID: 702115

Is the Next Big Step in Cancer Therapy Personalized Vaccines?

University of California San Diego Health

Tamara Strauss has been living with high-grade, stage IV pancreatic neuroendocrine cancer for more than three years. Current treatments, although effective for her, are highly toxic. Tamara enrolled in a first-of-its-kind, pilot study at Moores Cancer Center at UC San Diego Health to test a personalized vaccine using her unique cancer mutations to boost an anti-tumor immune response.

Released:
12-Oct-2018 10:05 AM EDT

Showing results

110 of 1365

Chat now!